The paradigm of mutant p53-expressing cancer stem cells and drug resistance

Y Shetzer, H Solomon, G Koifman… - …, 2014 - academic.oup.com
It is well accepted that expression of mutant p53 involves the gain of oncogenic-specific
activities accentuating the malignant phenotype. Depending on the specific cancer type …

[HTML][HTML] Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics

CP Tanase, AI Neagu, LG Necula… - World journal of …, 2014 - ncbi.nlm.nih.gov
Pancreatic cancer is one of the most aggressive and lethal malignancies. Despite
remarkable progress in understanding pancreatic carcinogenesis at the molecular level, as …

Sequential intra‐intercellular nanoparticle delivery system for deep tumor penetration

C Ju, R Mo, J Xue, L Zhang, Z Zhao, L Xue… - Angewandte …, 2014 - Wiley Online Library
To achieve deep tumor penetration of large‐sized nanoparticles (NPs), we have developed
a reversible swelling–shrinking nanogel in response to pH variation for a sequential intra …

Intracellular autofluorescence: a biomarker for epithelial cancer stem cells

I Miranda-Lorenzo, J Dorado, E Lonardo, S Alcala… - Nature …, 2014 - nature.com
Cancer stem cells (CSCs) are thought to drive tumor growth, metastasis and
chemoresistance. Although surface markers such as CD133 and CD44 have been …

Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells

S Krishnamurthy, KA Warner, Z Dong, A Imai, C Nör… - Stem …, 2014 - academic.oup.com
Head and neck squamous cell carcinomas (HNSCC) contain a small subpopulation of stem
cells endowed with unique capacity to generate tumors. These cancer stem cells (CSC) are …

[HTML][HTML] MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell

Y Lu, J Lu, X Li, H Zhu, X Fan, S Zhu, Y Wang, Q Guo… - BMC cancer, 2014 - Springer
Background Pancreatic cancer is one of the most aggressive cancers, and the
aggressiveness of pancreatic cancer is in part due to its intrinsic and extrinsic drug …

[HTML][HTML] Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine

O Isayev, V Rausch, N Bauer, L Liu, P Fan, Y Zhang… - Oncotarget, 2014 - ncbi.nlm.nih.gov
According to the cancer stem cell (CSC) hypothesis, the aggressive growth and early
metastasis of pancreatic ductal adenocarcinoma (PDA) is due to the activity of CSCs, which …

[HTML][HTML] Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1

B Bao, AS Azmi, A Aboukameel, A Ahmad… - Journal of Biological …, 2014 - ASBMB
Subpopulations of cancer stem cells (CSCs) or cancer stem-like cells (CSLCs) have been
identified from most tumors, including pancreatic cancer (PC), and the existence of these …

[HTML][HTML] Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma

A Saroufim, Y Messai, M Hasmim, N Rioux… - British journal of …, 2014 - nature.com
Background: Angiogenesis is essential for tumour growth and metastasis. There are
conflicting reports as to whether microvessel density (MVD) using the endothelial marker …

FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis

C Huang, J Du, K Xie - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2014 - Elsevier
Pancreatic cancer is a devastating disease with an overall 5-year survival rate less than 5%.
Multiple signaling pathways are implicated in the pathogenesis of pancreatic cancer, such …